 |
225Ac-lintuzumab |
|---|---|
| Trade Name | |
| Orphan Indication | Acute myeloid leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2014-11-25 00:00:00 |
| Sponsor | Actinium Pharmaceuticals, Inc.;379 Thornall Avenue, 6th Floor;Edison, New Jersey, 08837 |
| |
225Ac-lintuzumab |
|---|---|
| Trade Name | |
| Orphan Indication | Acute myeloid leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2014-11-25 00:00:00 |
| Sponsor | Actinium Pharmaceuticals, Inc.;379 Thornall Avenue, 6th Floor;Edison, New Jersey, 08837 |